Fulltext

Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital

Sax, Hugo ; Harbarth, Stephan ; Gavazzi, Gaetan ; Henry, Nicole ; Schrenzel, Jacques ; Rohner, Peter ; Michel, Jean Pierre ; Pittet, Didier

In: Age and Ageing, 2005, vol. 34, no. 5, p. 456-462

Zum persönliche Liste hinzufügen
    Titel
    • Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital
    Autor
    • Sax, Hugo. Infection Control Program, Geneva University Hospitals, Geneva, Switzerland
    • Harbarth, Stephan. Infection Control Program, Geneva University Hospitals, Geneva, Switzerland
    • Gavazzi, Gaetan. Department of Geriatrics, Geneva University Hospitals, Geneva, Switzerland
    • Henry, Nicole. Infection Control Program, Geneva University Hospitals, Geneva, Switzerland
    • Schrenzel, Jacques. Microbiology Laboratory, Geneva University Hospitals, Geneva, Switzerland
    • Rohner, Peter. Microbiology Laboratory, Geneva University Hospitals, Geneva, Switzerland
    • Michel, Jean Pierre. Department of Geriatrics, Geneva University Hospitals, Geneva, Switzerland
    • Pittet, Didier. Infection Control Program, Geneva University Hospitals, Geneva, Switzerland
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • Age and Ageing, 2005, vol. 34, no. 5, p. 456-462. Oxford University Press
    Andere elektronische Ausgabe
    OAI-PMH-ID
    • oai:doc.rero.ch:296034
    Summary
    Objectives: to determine the prevalence and characteristics of previously unknown methicillin-resistant Staphylococcus aureus (MRSA) carriers at admission. Design: two prospective case-control studies. Subjects: 1,621 elderly patients were screened for MRSA carriage within 24 hours after admission to a geriatric hospital in Geneva, Switzerland. Methods: risk factors associated with previously unknown MRSA carriage were determined in the derivation group, and the resulting risk score was evaluated in the validation cohort using logistic regression analysis. Results: prevalence of MRSA carriage at admission increased from 7.3% (53/724 patients) in 2001 to 8.7% (78/897 patients) in 2003, with a corresponding prevalence of unknown MRSA carriers of 4.6 and 5.8%, respectively. Three variables were independently associated with previously unknown MRSA carriage: recent antibiotic treatment (adjusted OR (aOR) 2.3; 95% CI 1.0-5.1), intra-hospital transfer (aOR 2.5; 95% CI 1.2-5.3), and hospitalization in the past 2 years (aOR 2.7; 95% CI 1.1-6.7). In the validation cohort, the probability of MRSA carriage increased across risk scores: 0 point, 4% prevalence (6/146); 1 point, 15% (21/136); and $2 points, 31% (21/68; P<0.001). The risk score showed good discrimination and calibration in both groups. Conclusions: our risk score, which used a simple additive point system to estimate the likelihood of unknown MRSA carriage, had good accuracy and generalised well in an independent sample of patients. Once validated in a clinical trial, our risk score may be used as a tool to optimise MRSA control